The (broken) promise of extracorporeal carbon dioxide removal—failure or future?
Open Access
- 23 January 2026
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 212 (3) , 414-419
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization RegistryThe Lancet, 2021
- Effect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory FailureJAMA, 2021
- Determinants of the effect of extracorporeal carbon dioxide removal in the SUPERNOVA trial: implications for trial designIntensive Care Medicine, 2019
- Extracorporeal Life Support for Adults With Respiratory Failure and Related IndicationsJAMA, 2019
- Feasibility and safety of extracorporeal CO2 removal to enhance protective ventilation in acute respiratory distress syndrome: the SUPERNOVA studyIntensive Care Medicine, 2019
- The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case–control studyIntensive Care Medicine, 2016
- Effects of extracorporeal carbon dioxide removal on work of breathing in patients with chronic obstructive pulmonary diseaseIntensive Care Medicine, 2016
- Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus ‘conventional’ protective ventilation (6 ml/kg) in severe ARDSIntensive Care Medicine, 2013
- Blood oxygenation and decarboxylation determinants during venovenous ECMO for respiratory failure in adultsIntensive Care Medicine, 2013
- Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective studyJAMA, 1979